-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>
The registered clinical study (CTR20212816) is a multi-center, single-arm, open, single-dose clinical study.
Dr.
Dr.
About hemophilia
Hemophilia is a bleeding disorder that slows the blood clotting process
About BBM-H901 injection
BBM-H901 injection is an AAV gene therapy drug with independent intellectual property rights of Faith Medicine.
BBM-H901 injection is one of the earliest AAV gene therapy drugs to carry out clinical research in China.
About Faith Medicine
Faith Pharmaceutical Group was established in September 2016.
Belief Medicine is committed to providing more effective and innovative solutions for single-gene genetic diseases, neurodegenerative diseases and some malignant diseases through adeno-associated virus (AAV) vector technology
For more information, please visit:
statements
Certain information contained in this document contains forward-looking statements